Glenmark Pharmaceuticals Inc., USA Recall: Ranolazine Extended-Release Tablets 1000mg, 60-
Glenmark Pharmaceuticals Inc., USA Recall: Ranolazine Extended-Release Tablets 1000mg, 60- is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Glenmark Pharmaceuticals Inc., USA; Product: Ranolazine Extended-Release Tablets 1000mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharma
| Recalling firm | Glenmark Pharmaceuticals Inc., USA |
|---|---|
| Product | Ranolazine Extended-Release Tablets 1000mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-320-60 |
| Reason for recall | CGMP Deviations |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Ongoing |
| Distribution | U.S. Nationwide |
| Recall initiated | 20250313 |
| Recall number | D-0335-2025 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →